Ticker Details
Sarepta Therapeutics, Inc. Sarepta Therapeutics Inc is a biotechnology company. It uses proprietary RNA-targeted technology platforms for developing pharmaceutical products to address serious diseases.
IPO Date:	July 12, 2012
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.98B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.75 | 2.95%
Avg Daily Range (30 D):	$0.41 | 2.37%
Avg Daily Range (90 D):	$0.43 | 2.40%

Institutional Daily Volume
Avg Daily Volume:	1.86M
Avg Daily Volume (30 D):	2.34M
Avg Daily Volume (90 D):	2.48M

Trade Size
Avg Trade Size (Sh.):	104
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	70

Institutional Trades
Total Institutional Trades:	14,177
Avg Institutional Trade:	$4.06M
Avg Institutional Trade (30 D):	$4.93M
Avg Institutional Trade (90 D):	$5.13M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	4

Market Closing Trades
Avg Closing Trade:	$8.77M
Avg Closing Trade (30 D):	$8.83M
Avg Closing Trade (90 D):	$9.37M
Avg Closing Volume:	138.96K

News

Jul 11, 2026 @ 8:30 PM 2 Beaten-Down Stocks That Still Aren't Worth Buyin... Source: Prosper Junior Bakiny

May 20, 2026 @ 3:15 PM My Top 3 Biotech Stocks for May 2026 Source: Jeff Siegel

May 18, 2026 @ 6:33 PM Protein Synthesis Research Market to Reach $42.8 B... Source: Bcc Research

Mar 27, 2026 @ 5:09 PM Nasdaq 100 Enters Correction As 30-Year Yields Nea... Source: Piero Cingari

Jan 26, 2026 @ 1:41 PM Stock Market Today: Dow Futures Gain, S&P 500 Slip... Source: Rishabh Mishra

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-1.33	$-.05	$3.15
Diluted EPS	$-1.44	$-.05	$2.88
Revenue	$1.97B	$401.25M	$730.8M
Gross Profit
Net Income / Loss	$-136.73M	$-4.89M	$330.96M
Operating Income / Loss	$-143.25M	$13.29M	$358.43M
Cost of Revenue
Net Cash Flow	$55.1M	$103.7M	$-336.83M
PE Ratio

Splits
Jul 12, 2012	1:6